Literature DB >> 11912114

Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance.

Mark J Kupersmith1, Therese Alban, Barbara Zeiffer, Daniel Lefton.   

Abstract

The location and extent of an abnormal signal on MRI of the optic nerve affected by optic neuritis are said to correlate with the severity of initial visual loss and recovery. We used gadolinium-enhanced fat-suppressed MRI to show abnormal enhancement of the optic nerve to determine the sensitivity of this modality in acute optic neuritis and whether the abnormal enhancement correlates with presenting visual deficits or recovery. A total of 107 patients, 93 with follow-up (68 steroid treated), were included; 101 patients had enhancement of the affected optic nerve and no unaffected nerve enhanced. The baseline visual performance was similar between nerves with and without enhancement. Optic nerves with enhancement in the optic canal had poorer colour vision (P = 0.04) and nerves with all segments involved had worse threshold perimetry (P = 0.001) and colour vision (P = 0.008). Nerves with enhancement >10 mm had worse threshold perimetry (P = 0.004), while nerves with enhancing segments >17 mm had poorer baseline visual acuity (P = 0.02), threshold perimetry (P = 0.009) and colour vision (P = 0.01). For all parameters of vision, recovery was similar regardless of location or length of abnormal enhancement. Abnormal contrast enhancement of the optic nerve is a sensitive (94%) finding in acute optic neuritis and is absent in unaffected or previously affected optic nerves. Although lesions involving the canal or longer segments of optic nerve have worse starting vision, the location and length of enhancement are not predictive of recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912114     DOI: 10.1093/brain/awf087

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  48 in total

Review 1.  Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.

Authors:  Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 2.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

3.  Clinical profile of simultaneous bilateral optic neuritis in adults.

Authors:  J de la Cruz; M J Kupersmith
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 4.  Optical coherence tomography: a window into the mechanisms of multiple sclerosis.

Authors:  Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary Cutter; Laura J Balcer
Journal:  Nat Clin Pract Neurol       Date:  2008-12

Review 5.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

Review 6.  MR imaging in multiple sclerosis: review and recommendations for current practice.

Authors:  K-O Lövblad; N Anzalone; A Dörfler; M Essig; B Hurwitz; L Kappos; S-K Lee; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-17       Impact factor: 3.825

7.  Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.

Authors:  Thomas Jenkins; Olga Ciccarelli; Ahmed Toosy; Katherine Miszkiel; Claudia Wheeler-Kingshott; Daniel Altmann; Laura Mancini; Steve Jones; Gordon Plant; David Miller; Alan Thompson
Journal:  Hum Brain Mapp       Date:  2010-02       Impact factor: 5.038

8.  In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.

Authors:  Leon C Ho; Ian P Conner; Chi-Wai Do; Seong-Gi Kim; Ed X Wu; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-24       Impact factor: 4.799

9.  Improved diffusion tensor imaging of the optic nerve using multishot two-dimensional navigated acquisitions.

Authors:  Ha-Kyu Jeong; Blake E Dewey; Jane A T Hirtle; Patrick Lavin; Subramaniam Sriram; Siddharama Pawate; John C Gore; Adam W Anderson; Hakmook Kang; Seth A Smith
Journal:  Magn Reson Med       Date:  2014-09-26       Impact factor: 4.668

Review 10.  Pain in optic neuropathies.

Authors:  Stefania Bianchi Marzoli; Alessandra Criscuoli
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.